Check with your healthcare provider or pharmacist if you take other oral medicines
Never switch medications without medical guidance
FDA pharmacovigilance review of FAERS reports for compounded GLP-1 products has documented cases of dosing errors, adverse events, and product quality concerns that the agency directly attributes to the regulatory gap between compounded and FDA-approved finished dosage forms (Hoffman et al., 2025)
A single episode of vomiting in the first week at a new dose is common and not a reason to stop
Weibull distribution modeling ( = 0.59, 95% CI 0.580.61) indicated these NAEs are likely to occur during initial treatment phases (Table 2, Fig
However, emerging research suggests that Ozempic, primarily known for its role in managing type 2 diabetes, may offer promising benefits in supporting weight management goals during menopause